[
  "[Time]: December 31, 2023 [SEP]\n[row 0]: Assets [SEP] \n[row 1]: Current Assets [SEP] \n[row 2]: Cash and cash equivalents | $6,841 [SEP] \n[row 3]: Short-term investments | $252 [SEP] \n[row 4]: Accounts receivable (net of allowance for doubtful accounts of $88) | $10,349 [SEP] \n[row 5]: Inventories (excludes inventories of $3,468 classified in Other assets - see Note 8) | $6,358 [SEP] \n[row 6]: Other current assets | $8,368 [SEP] \n[row 7]: Total current assets | $32,168 [SEP] \n[row 8]: Investments | 252 [SEP] \n[row 9]: Property, Plant and Equipment (at cost) [SEP] \n[row 10]: Land | $14,966 [SEP] \n[row 11]: Buildings | $17,763 [SEP] \n[row 12]: Machinery, equipment and office furnishings | $8,262 [SEP] \n[row 13]: Construction in progress | $8,262 [SEP] \n[row 14]:   | $41,317 [SEP] \n[row 14]: Less: accumulated depreciation | $18,266 [SEP] \n[row 15]:   | $23,051 [SEP] \n[row 15]: Goodwill | $21,197 [SEP] \n[row 16]: Other Intangibles, Net | $18,011 [SEP] \n[row 17]: Other Assets | $11,996 [SEP] \n[row 18]: Total Assets | $106,675 [SEP] \n\n[row 19]: Liabilities and Equity [SEP] \n[row 20]: Current Liabilities [SEP] \n[row 21]: Loans payable and current portion of long-term debt | $1,372 [SEP] \n[row 22]: Trade accounts payable | $3,922 [SEP] \n[row 23]: Accrued and other current liabilities | $15,766 [SEP] \n[row 24]: Income taxes payable | $2,649 [SEP] \n[row 25]: Dividends payable | $1,985 [SEP] \n[row 26]: Total current liabilities | $25,694 [SEP] \n[row 27]: Long-Term Debt | $33,683 [SEP] \n[row 28]: Deferred Income Taxes | $871 [SEP] \n[row 29]: Other Noncurrent Liabilities | $8,792 [SEP] \n[row 30]: Merck & Co., Inc. Stockholders' Equity [SEP] \n[row 31]: Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares | $1,788 [SEP] \n[row 34]: Other paid-in capital | $44,509 [SEP] \n[row 35]: Retained earnings | $53,895 [SEP] \n[row 36]: Accumulated other comprehensive loss | $5,161 [SEP] \n\n[row 37]:   | $95,031 [SEP] \n[row 37]: Less treasury stock, at cost: 1,045,470,249 shares in 2023 and 1,039,269,638 shares in 2022 | $57,450 [SEP] \n[row 37]: Total Merck & Co., Inc. stockholders' equity | $37,581 [SEP] \n\n[row 37]: Noncontrolling Interests | $54 [SEP] \n[row 38]: Total equity | $37,635 [SEP]\n[row 38]:   | $106,675 [SEP]"
]